KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Ionis Pharmaceuticals (IONS) Leases (2021 - 2025)

Ionis Pharmaceuticals has reported Leases over the past 7 years, most recently at $238.5 million for Q4 2025.

  • Quarterly results put Leases at $238.5 million for Q4 2025, up 47.38% from a year ago — trailing twelve months through Dec 2025 was $238.5 million (up 47.38% YoY), and the annual figure for FY2025 was $238.5 million, up 47.38%.
  • Leases for Q4 2025 was $238.5 million at Ionis Pharmaceuticals, down from $242.0 million in the prior quarter.
  • Over the last five years, Leases for IONS hit a ceiling of $242.0 million in Q3 2025 and a floor of $18.0 million in Q4 2021.
  • Median Leases over the past 5 years was $170.7 million (2023), compared with a mean of $169.1 million.
  • Biggest five-year swings in Leases: surged 910.04% in 2022 and later decreased 6.0% in 2025.
  • Ionis Pharmaceuticals' Leases stood at $18.0 million in 2021, then surged by 910.04% to $181.5 million in 2022, then dropped by 5.31% to $171.9 million in 2023, then fell by 5.84% to $161.9 million in 2024, then skyrocketed by 47.38% to $238.5 million in 2025.
  • The last three reported values for Leases were $238.5 million (Q4 2025), $242.0 million (Q3 2025), and $163.9 million (Q2 2025) per Business Quant data.